financetom
Business
financetom
/
Business
/
Allegiant Travel Q2 adjusted EPS beats estimates, revenue rises 3.5%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Allegiant Travel Q2 adjusted EPS beats estimates, revenue rises 3.5%
Aug 4, 2025 1:19 PM

Overview

* Allegiant Q2 adjusted EPS of $1.23 beats analyst expectations, per LSEG data

* Company's Q2 revenue rises 3.5% yr/yr, beating analyst expectations, per LSEG data

* Allegiant operated record 37,000 flights, achieving 99.9% controllable completion factor

Outlook

* Allegiant forecasts full-year 2025 capacity to be flat year-over-year

* Company expects Q3 2025 adjusted EPS between ($1.75) and ($2.75)

* Allegiant anticipates full-year 2025 adjusted EPS to exceed $2.25

* Company sees Q3 2025 fuel cost per gallon at $2.55

Result Drivers

* RECORD FLIGHTS - Allegiant operated 37,000 flights, the highest quarterly total in company history, per CEO Gregory Anderson

* COST CONTROLS - Improved margins attributed to higher productivity and strong cost controls

* ANCILLARY REVENUE - New pricing tools and product expansions increased ancillary revenue by $3 per passenger in the first half of 2025

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $689.40 $684.30

Revenue mln mln (10

Analysts

)

Q2 Beat $1.23 $0.76

Adjusted (12

EPS Analysts

)

Q2 EPS -$3.62

Q2 Net -$65.20

Income mln

Q2 -$67.50

Operatin mln

g Income

Q2 -$88.60

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 10 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the airlines peer group is "buy."

* Wall Street's median 12-month price target for Allegiant Travel Co ( ALGT ) is $56.00, about 14.1% above its August 1 closing price of $48.12

* The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 7 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ondas Says Subsidiary Delivers Counter-Drone Solution to German State Police
Ondas Says Subsidiary Delivers Counter-Drone Solution to German State Police
Mar 11, 2026
09:18 AM EST, 02/17/2026 (MT Newswires) -- Ondas ( ONDS ) said Tuesday its subsidiary Sentrycs has delivered and deployed its counter-drone solution to a German State Police office. Financial terms weren't disclosed. The company said the system is designed to detect, identify and take control of unauthorized drones without jamming or kinetic engagement. ...
Moleculin Biotech Says Japan Patent Office Issues Notice of Allowance for Patent Covering Annamycin; Shares Rise Pre-Bell
Moleculin Biotech Says Japan Patent Office Issues Notice of Allowance for Patent Covering Annamycin; Shares Rise Pre-Bell
Mar 11, 2026
09:20 AM EST, 02/17/2026 (MT Newswires) -- Moleculin Biotech ( MBRX ) said Tuesday that Japan's Patent Office has issued a notice of allowance for a patent covering Annamycin. A patent from the application is slated to be issued in the coming months, the company said. Moleculin's drug candidate Annamycin is in development to treat acute myeloid leukemia and other...
Natural Gas Trading at a Four-Month Low as Mild Weather to Cut Into Demand
Natural Gas Trading at a Four-Month Low as Mild Weather to Cut Into Demand
Mar 11, 2026
09:21 AM EST, 02/17/2026 (MT Newswires) -- Natural gas futures fell to a four-month low early Tuesday as long-term forecasts see mild weather on the way for most states, cutting into heating demand for the fuel. Gas for March delivery was last seen down US$0.17 to US$3.08 per million British thermal units, the lowest since Oct. 17. Prices dropped to...
Novo Nordisk Gets European Commission Approval for Higher-Dose Wegovy Injectable
Novo Nordisk Gets European Commission Approval for Higher-Dose Wegovy Injectable
Mar 11, 2026
09:25 AM EST, 02/17/2026 (MT Newswires) -- Novo Nordisk ( NVO ) said Tuesday the European Commission has approved a 7.2 mg once-weekly maintenance dose of Wegovy for adults with obesity. The approval, based on positive opinion from the European Medicines Agency's scientific committee, is intended to provide another option for adults who need more weight loss after being on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved